Trade-related policy coherence and access to essential medicines

Journal of World Trade

Volumn 42, Issue 4, 2008, Pages 619-640

  Saggi, Kamal ^a  

^a SOUTHERN METHODIST UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDICINE; REGIONAL TRADE; TERMS OF TRADE; TRADE AGREEMENT; TRADE POLICY;

EID: 51049107310     PISSN: 10116702     EISSN: None     Source Type: Journal    
DOI: 10.54648/trad2008026     Document Type: Article

References (26)

1. Attan, Amir (2004), How Do Patents and Economic Policies Affect Assess to Essential Medicines in Developing Countries?, 23 Health Affairs 3, 155-167.
2. Chaudharii, Shubham, Pinelopi K. Goldberg and Partle Jia (2006), Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India, American Economic Review, forthcoming.
3. Chaudhuri, Sudip (2005), The WTO and India's Pharmaceutical Industry: Patent Protection, TRIPS, and Developing Countries (New Delhi: Oxford University Press).
4. Correa, Carlos M. (2004), Protecting Test Data for Pharmaceutical and Agrochemical Products under Free Trade Agreements, mimeo.
5. Danzon, Patricia, and Li-Wei Chao (2000), Cross-national Price Differences for Pharmaceuticals: How Large, and Why?, 19 Journal of Health Economics, 159-195.
6. Deaton, Angus (2004), Health in an Age of Globalization, Princeton University, mimeo.
7. Department for International Development (2004), Increasing Access to Essential Medicines in the Developing World: UK Government Policy and Plans (London: Department for International Development).
8. Fink, Carsten (2003), Implementing the Doha Mandate on TRIPS and Public Health, Trade Note 5 (Washington, D.C.: World Bank).
9. Fink, Carsten (2005), Tightening TRIPS: The Intellectual Property Provision of Recent US Free Trade Agreements, Trade Note 20 (Washington, D.C.: World Bank).
10. Gelders, Susanne, Margaret Ewen, Nakae Noguchi and Richard Laing (2006), Prices, Availability and Affordability: An International Comparison of Chronic Disease Medicines (World Health Organization).
11. Granville, Brigitte (ed.) (2002), The Economics of Essential Medicines (London: Royal Institute of International Affairs, International Economics Programme).
12. Kaplan, Warren, and Richard Laing (2005), Local Production of Pharmaceuticals: Industrial Policy and Access to Medicines, HNP Discussion Paper (Washington, D.C.: World Bank).
13. Kremer, Michael (2002), Pharmaceuticals and the Developing World, 16 Journal of Economic Perspectives 4, 67-90.
14. Li, Changying, and Keith Maskus (2006). The Impact of Parallel Imports on Investments in Cost-reducing Research and Development, 68 Journal of International Economics, 443-455.
15. Malueg, David, and Marius Schwartz (1994), Parallel Imports, Demand Dispersion, and International Price Discrimination, 37 Journal of International Economics, 167-195.
16. Maskus, Keith (2000), Intellectual Property Rights in the Global Economy (Washington, D.C.: Institute for International Economics).
17. Maskus, Keith, and Mattias Ganslandt (2002), "Parallel Trade in Pharmaceutical Products: Implications for Procuring Medicines for Poor Countnies", in Brigitte Granville (ed.), The Economics of Essential Medicines (London: Royal Institute of International Affairs, International Economics Programme).
18. Musungu, Sisule, and Cecilia Oh (2005), The Use of Flexibilities in TRIPS by Developing Countries: Can They Promote Access to Medicines?, Commission on Intellectual Property Rights, Innovation and Public Health, Study 4C (Geneva: WHO).
19. Olcay, Muge, and Richard Laing (2005), Pharmaceutical Tariffs: What is Their Effect on Prices, Protection of Local Industry and Revenue Generation?, paper prepared for the Commission on Intellectual Property Rights, Innovation and Public Health (Geneva: WHO).
20. Pecoul, Bernard, Pierre Chirac, Patrice Trouiller and Jacques Pinel (1999), Access to Essential Drugs in Poor Countries, 281 Journal of the American Medical Association, 361-367.
21. Roffe, Pedro (2007), Intellectual Property Provisions in Bilateral and Regional Trade Agreements: The Challenges of Implementation (Centre for International Enviromnental
22. Vivas-Eugui David and Von Braun Johanna (2007), Beyond FTA Negotiations: the Challenge of implementing the new generation of Intellectual Property Obligations, Intellectual Property and Information Wealth (Praeger Publishers (Greenwood)).
23. Scherer, Frederic M., and Jayshree Watal (2002), Post-TRIPS Options for Access to Patented Medicines in Developing Nations, 5 Journal of International Economic Law, 913-939.
24. UNCTAD and ICTSD (2005), Resource Book on TRIPS and Development (Geneva: UNCTAD)
25. WHO and WTO (2002), WTO Agreements and Public Health (Geneva: WTO/ WHO).
26. WHO (2006), World Health Report (Geneva: WHO).